Genervon to present at the American Society for Experimental Neurotherapeutics (ASENT) 2019 Global Healthcare Conference

ASENT logo main.png

March 3, 2019

Genervon Biopharmaceuticals is scheduled to present again this year at the ASENT 2019 Annual Meeting and Global Healthcare Conference on Neurotherapeutics in Maryland on March 28. Genervon will be presenting its published papers, “GM604 regulates developmental neurogenesis pathways and the expression of genes associated with Amyotrophic Lateral Sclerosis” ( and “GM604 Attenuates Alzheimer’s Disease Pathology in APP Mice” (

The American Society for Experimental Neurotherapeutics Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders.